Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

everolimus

EU orphan designation number: EU/3/07/449
Active ingredient: everolimus
Indication: Treatment of renal cell carcinoma
Sponsor: Novartis Europharm Limited
Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Afinitor on 03/08/2009 with the number EU/1/09/538

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/06/2007 Centralised Orphan - Designation EMEA/OD/005/07 (2007)2489 of 05/06/2007
18/07/2011 Centralised Orphan - Removal of orphan designation from Community Register